Percutaneous Retrieval of Embolized Left Atrial Appendage Occlusion Device From Mitral Valve Apparatus Authors: Muslim Madhag, Bruno Chan Chin, Samer Arnous, Cormac O’Connor, Thomas Kiernan Published: 2026 ABSTRACT BackgroundLeft atrial appendage occlusion (LAAO) is a safe and effective intervention for patients with atrial fibrillation who are unable to tolerate anticoagulation. Despite the safety of the procedure, complications including device displacement are a potential risk.Case SummaryA frail 84-year-old man underwent LAAO implantation, which was complicated by an early device displacement into the mitral apparatus, precipitating myocardial infarction and cardiogenic shock. The device was retrieved percutaneously with 2 snare wires, with a good patient recovery on follow-up.DiscussionDevice displacement to the mitral apparatus is a rare complication with high mortality. Transcatheter device retrieval is feasible with the right skills and equipment with good final results.Take-Home MessagesEarly dislodgement of LAAO devices, though rare, can cause acute mitral valve obstruction and cardiogenic shock. Mechanical obstruction and ischemic events may coexist, necessitating rapid multimodality imaging and parallel management strategies. History of Presentation A frail 84-year-old man was referred for a left atrial appendage occlusion (LAAO) following a stroke multidisciplinary team discussion, due to intolerance to direct oral anticoagulants. Based on the preprocedural cardiac computed tomography and transesophageal echocardiography, a 34-mm Amplatzer Amulet device was implanted successfully with satisfactory positioning and stability, confirmed by tug test (Figure 1). The sizing was done based on the Abbot guidelines for devices guided by the computed tomography measurements of the maximum landing zone (28.7 mm) (Figure 2).Take-Home Messages•Early dislodgement of left atrial appendage occlusion devices, although rare, can cause acute mitral valve obstruction and cardiogenic shock.•Mechanical obstruction and ischemic events may coexist, necessitating rapid multimodality imaging and parallel management strategies.Figure 134-mm Amplatzer Amulet Device Tug ReleaseFigure 2Computed Tomography Scan Showing the Left Atrial Appendage Landing Zone Take-Home Messages •Early dislodgement of left atrial appendage occlusion devices, although rare, can cause acute mitral valve obstruction and cardiogenic shock.•Mechanical obstruction and ischemic events may coexist, necessitating rapid multimodality imaging and parallel management strategies. •Early dislodgement of left atrial appendage occlusion devices, although rare, can cause acute mitral valve obstruction and cardiogenic shock. Early dislodgement of left atrial appendage occlusion devices, although rare, can cause acute mitral valve obstruction and cardiogenic shock. •Mechanical obstruction and ischemic events may coexist, necessitating rapid multimodality imaging and parallel management strategies. Mechanical obstruction and ischemic events may coexist, necessitating rapid multimodality imaging and parallel management strategies. 34-mm Amplatzer Amulet Device Tug Release Computed Tomography Scan Showing the Left Atrial Appendage Landing Zone Twelve hours postimplantation at 3 am, the patient developed acute chest pain. Electrocardiography (ECG) demonstrated acute ischemic changes, with ST-segment elevation in aVR and V1 and reciprocal diffuse ST-segment depression (Figure 3). On review, he was found to be hemodynamically unstable, with a systolic blood pressure of 48 mm Hg. Intervention was mainly limited to percutaneous management considering comorbidities (including previous sternotomy) and frailty.Figure 3Electrocardiogram During Episode of Acute Chest Pain, Demonstrating ST-Segment Elevation in aVR and V1, and Diffuse ST-Segment Depression Electrocardiogram During Episode of Acute Chest Pain, Demonstrating ST-Segment Elevation in aVR and V1, and Diffuse ST-Segment Depression Past Medical History The patient has a background of atrial fibrillation, recurrent hematuria, and anemia when he was on direct oral anticoagulants, secondary to bladder cancer. Following Urology outpatient review and stroke meeting, he was deemed to have a good overall life expectancy and would benefit from LAAO. The patient also had a previous coronary artery bypass graft surgery with significant native coronary disease. Differential Diagnosis Because of the acute onset of chest pain and ST segment changes on ECG, the main differential diagnoses include myocardial infarction leading to acute cardiac failure and cardiogenic shock, cardiac tamponade, or device migration. Investigations A bedside transthoracic echocardiography (TTE) excluded pericardial tamponade, and showed good left ventricular systolic function was preserved. However, it revealed embolization of the Amulet device, fully obstructing the mitral anulus apparatus (Figures 4 and 5).Figure 4TTE, in Parasternal Long Axis View, Demonstrating Device Migration and Obstruction of Mitral Valve ApparatusFigure 5Transthoracic Echocardiogram, in Short Axis View, Demonstrating Device Displacement to the Mitral Apparatus TTE, in Parasternal Long Axis View, Demonstrating Device Migration and Obstruction of Mitral Valve Apparatus Transthoracic Echocardiogram, in Short Axis View, Demonstrating Device Displacement to the Mitral Apparatus Management The patient was immediately resuscitated with intravenous fluids and the cardiac arrest call was activated for support. Intravenous heparin (10,000 international units) and adrenaline were administered to prevent thrombus-related complications and control blood pressure. Following adrenaline administration, the patient developed supraventricular tachycardia, and became hemodynamically unstable. However, no chest compressions were administered, and a synchronized direct current cardioversion (DCCV) was administered to restore sinus rhythm. Post DCCV, the systolic blood pressure improved to 167 mm Hg; however, he had persistent chest pain. A repeat TTE was performed to confirm device location post DCCV and it showed that the device had partially migrated away from the mitral valve back into the left atrium (Figure 6). After hemodynamic resuscitation, the patient was transferred to the catheterization laboratory with anesthetic support, for assessment of the coronary arteries and device retrieval.Figure 6Repeat Transthoracic Echocardiogram Post Direct Current Cardioversion, in Long-Axis View, Demonstrating the Device Had Moved Back into the Left Atrium Repeat Transthoracic Echocardiogram Post Direct Current Cardioversion, in Long-Axis View, Demonstrating the Device Had Moved Back into the Left Atrium Coronary angiography confirmed the presence of a right coronary artery stenosis (Figure 7). Despite the hemodynamic stability, chest pain and ST changes did not improve so it was decided to proceed with plain old balloon angioplasty (POBA), to avoid the need for dual antiplatelet therapy (DAPT), given the potential requirement for surgical intervention in case transcatheter device retrieval failed. Following POBA, the ST-segment changes partially recovered, and the patient's symptoms resolved. No further angioplasty was pursued due to recovery of the ST changes and the highly calcific nature of the stenosis, which was difficult to cross.Figure 7Coronary Angiogram Showing Mid–Right Coronary Artery Stenosis Coronary Angiogram Showing Mid–Right Coronary Artery Stenosis Retrieval of the Amulet device was attempted using endovascular snares. The intracardiac echocardiography catheter was inserted via the right femoral vein through a 10-F sheath. An SL1 catheter was used to access the previous septal puncture through which a 14-F Torquevue catheter was passed. The first 35-mm gooseneck snare was introduced through a JR4 guide under the guidance of intracardiac echocardiography (Figure 8). Using the first endovascular snare, the LAAO device was held sideways and fixed in place to help stabilize and orient the device in a favorable way for retrieval. A second 35-mm snare was introduced through a new (this time left) femoral access with an Extra Back-up 3.5 guide catheter. This catheter was used as its braided structure is more rigid, which provides directionality to the snare and reduces the chance of the catheter suffering from a consertina deformation during device retrieval. The second snare was used to grasp the Amulet device connector hub, and the device was pulled into the catheter. The LAAO device was successfully retrieved in a procedure lasting 4 hours (Figure 9).Figure 8Intracardiac Echocardiography Image of the Left Atrial Appendage Occlusion DeviceFigure 9Radiographic Image Showing 2 Intravascular Snares Holding the Amulet Left Atrial Appendage Occlusion Device With Intracardiac Echocardiography Probe Intracardiac Echocardiography Image of the Left Atrial Appendage Occlusion Device Radiographic Image Showing 2 Intravascular Snares Holding the Amulet Left Atrial Appendage Occlusion Device With Intracardiac Echocardiography Probe Outcome and Follow-Up The patient returned to the coronary care unit. A post procedural TTE confirmed there was no pericardial effusion, and the mitral valve was intact (Figures 10 and 11). The patient recovered well without neurological or cardiac complications and was discharged home. In the outpatient follow-up after 4 weeks, he was feeling well with no evidence of further complications. Due to the complications, the case was discussed with the patient, and it was agreed that the patient will continue with aspirin alone and not proceed with a further LAAO procedure.Figure 10Transthoracic Echocardiography 1 Day Post-Device Retrieval, in Parasternal Long-Axis ViewFigure 11Transthoracic Echocardiography in 4-Chamber View, with Doppler, 1 day Post Device Retrieval Transthoracic Echocardiography 1 Day Post-Device Retrieval, in Parasternal Long-Axis View Transthoracic Echocardiography in 4-Chamber View, with Doppler, 1 day Post Device Retrieval Discussion This case highlights the importance of early recognition and cautious approach of early complications related to LAAO devices to improve outcomes and avoid surgical interventions in otherwise frail patients. Major periprocedural adverse events have been reported in 2% to 3% of LAAO implantation cases.1 With an improvement in operator implantation technique, device design, and improved computer tomography or transesophageal-based sizing, device embolization is rare, with an incidence of 0.1% in recent studies. However, it remains a serious complication that carries a mortality risk as high as 20%,2 requiring timely and effective management. Most (65%-70%) device embolization events occur in the acute setting, in the first 24 hours, or in the early phase (<30 days).3 Despite the proper planning and device sizing as per the manufacturing guideline and confirming device stability with tug test, embolization is possible due to anatomical variability of the left atrial appendage. The management and degree of risk associated with device embolization varies according to the anatomical location of the embolized device. In a literature search, the most common location is the descending aorta (30%), followed by left atrium (24%) and left ventricle (20%).4 According to the European Left Atrial Appendage Closure Club, if devices embolize to the left atrium, a percutaneous approach could be attempted first, followed by surgical removal, with both procedures carrying an intermediate risk.5 Emergent surgery would be warranted if the device is entangled in the mitral apparatus, with hemodynamic compromise, and it is not possible to mobilize the device into the left ventricle percutaneously. However, this patient was very frail, rendering the surgical option unlikely, yet the potential need for surgical option was considered and DAPT was avoided to facilitate this. In this patient's case, it was fortunate that following the synchronized DCCV, the device moved from the mitral apparatus back to the left atrium. The exact mechanism of the reverse migration has not been previously described in the literature. Although the synchronized direct current cardioversion itself is unlikely to generate sufficient mechanical force to dislodge the device directly, the abrupt restoration of organized atrial contraction and coordinated atrioventricular synchrony may have acutely altered left atrial pressure, transmitral gradients, and ventricular filling dynamics, which contributed to the migration of the device out of the mitral apparatus.6 The acute obstruction of the mitral valve apparatus by the embolized device likely caused a significant reduction in cardiac output, leading to global hypoperfusion and coronary flow mismatch. In a patient with preexisting coronary artery disease, with previous coronary artery bypass graft and residual native vessel disease, this hemodynamic insult would be sufficient to precipitate a supply-demand mismatch, presenting as a myocardial infarction. A less likely cause for this presentation was embolization of thrombi formed on the dislodged device, which was treated with unfractionated heparin. Although the hemodynamic stress caused by the mitral valve obstruction was the most likely cause of the chest pain, the ECG changes of ST-segment elevation did not resolve after the device migrated back into the left atrium. For that reason, a coronary angiogram was performed in the first instance, which found a fixed mid–right coronary artery stenosis, with no acute thrombi. Although drug-eluting stents are the standard of care in acute coronary syndromes,7 due to superior long-term patency, their use mandates prolonged DAPT, which would have complicated the management of a potentially unstable intracardiac foreign body requiring surgical retrieval. Obagi and Schoenfeld8 have previously described a case in which POBA was successful in a patient with concomitant acute intracranial hemorrhage and ST-elevation myocardial infarction, and would not tolerate DAPT or anticoagulation.8 Similarly, in this case, for a patient who has a high bleeding risk or will have eminent surgery, and was in cardiogenic shock, POBA was a pragmatic and patient-centered approach, which focused on achieving adequate coronary flow without committing the patient to prolonged DAPT. This case exemplifies the complexity of decisions when multiple life-threatening processes coexist: mechanical obstruction, myocardial ischemia, arrhythmia, and device embolization. A staged, physiology-driven approach, stabilizing rhythm and coronary perfusion first, followed by definitive device retrieval, was critical to the favorable outcome. Conclusions LAAO is an effective alternative to anticoagulation in patients with atrial fibrillation who are unsuitable for long-term pharmacological therapy. However, rare complications such as device displacement can lead to catastrophic events, including myocardial infarction and impaired cardiac output and cardiogenic shock. It is imperative to recognize complications in the early postoperative period and to individualize interventions when competing procedural risks are present, to increase the chances of a favorable outcome. Funding Support and Author Disclosures The authors have reported that they have no relationships relevant to the contents of this paper to disclose.Visual SummaryTimeline of Events From LAAO Device Implantation to Migration Causing Mitral Obstruction and Percutaneous RetrievalTimelineEventsDay 0 Hour 0Successful implantation of 34-mm Amplatzer Amulet LAAO device in an 84-year-old man. Hour 8Sudden onset of central chest pain. Systolic blood pressure of 48 mm Hg. ECG demonstrates ST-segment elevation in aVR and V1. Immediate resuscitation with intravenous fluids, cardiac arrest team called for support. Bedside TTE demonstrates displacement of LAAO device into the mitral valve apparatus. Hour 8Intravenous heparin and adrenaline are administered. Patient develops supraventricular tachycardia. A synchronized DCCV was administered, reverting the patient to sinus rhythm, with immediate improvement of blood pressure. Hour 8Repeat TTE demonstrates the device migrated out of the mitral valve apparatus into the left atrium. Hours 9-13The patient was transferred to the catheterization laboratory for a coronary angiogram and attempt at percutaneous device retrieval. Coronary angiogram demonstrated severe stenosis in native right coronary artery. Decision made to proceed with POBA rather than drug-eluting stent due to possibility of urgent surgery for device retrieval, leading to improvement in chest pain and resolution of ST-segment elevation. LAAO device retrieved successfully percutaneously, with dual-snare approach. Hour 14Patient transferred back to coronary care unit for recovery. No residual cardiac or neurological deficits.Day 2Patient discharged home with no further complications.Day 30Patient reviewed in outpatient setting, feeling well and clinically stable. Visual SummaryTimeline of Events From LAAO Device Implantation to Migration Causing Mitral Obstruction and Percutaneous RetrievalTimelineEventsDay 0 Hour 0Successful implantation of 34-mm Amplatzer Amulet LAAO device in an 84-year-old man. Hour 8Sudden onset of central chest pain. Systolic blood pressure of 48 mm Hg. ECG demonstrates ST-segment elevation in aVR and V1. Immediate resuscitation with intravenous fluids, cardiac arrest team called for support. Bedside TTE demonstrates displacement of LAAO device into the mitral valve apparatus. Hour 8Intravenous heparin and adrenaline are administered. Patient develops supraventricular tachycardia. A synchronized DCCV was administered, reverting the patient to sinus rhythm, with immediate improvement of blood pressure. Hour 8Repeat TTE demonstrates the device migrated out of the mitral valve apparatus into the left atrium. Hours 9-13The patient was transferred to the catheterization laboratory for a coronary angiogram and attempt at percutaneous device retrieval. Coronary angiogram demonstrated severe stenosis in native right coronary artery. Decision made to proceed with POBA rather than drug-eluting stent due to possibility of urgent surgery for device retrieval, leading to improvement in chest pain and resolution of ST-segment elevation. LAAO device retrieved successfully percutaneously, with dual-snare approach. Hour 14Patient transferred back to coronary care unit for recovery. No residual cardiac or neurological deficits.Day 2Patient discharged home with no further complications.Day 30Patient reviewed in outpatient setting, feeling well and clinically stable. Timeline of Events From LAAO Device Implantation to Migration Causing Mitral Obstruction and Percutaneous Retrieval